<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rath SK</submitter><funding>DZHK grant</funding><funding>DFG grant</funding><pagination>119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11350970</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cardiac fibrosis is the hallmark of all forms of chronic heart disease. Activation and proliferation of cardiac fibroblasts are the prime mediators of cardiac fibrosis. Existing studies show that ROS and inflammatory cytokines produced during fibrosis not only signal proliferative stimuli but also contribute to DNA damage. Therefore, as a prerequisite to maintain sustained proliferation in fibroblasts, activation of distinct DNA repair mechanism is essential.&lt;h4>Result&lt;/h4>In this study, we report that TET3, a DNA demethylating enzyme, which has been shown to be reduced in cardiac fibrosis and to exert antifibrotic effects does so not only through its demethylating activity but also through maintaining genomic integrity by facilitating error-free homologous recombination</pubmed_abstract><journal>Clinical epigenetics</journal><pubmed_title>Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair response.</pubmed_title><pmcid>PMC11350970</pmcid><funding_grant_id>ZE523/2-3</funding_grant_id><funding_grant_id>MD23</funding_grant_id><pubmed_authors>Zeisberg EM</pubmed_authors><pubmed_authors>Schlosser D</pubmed_authors><pubmed_authors>Rath SK</pubmed_authors><pubmed_authors>Tampe B</pubmed_authors><pubmed_authors>Zeisberg M</pubmed_authors><pubmed_authors>Nyamsuren G</pubmed_authors><pubmed_authors>Yu DS</pubmed_authors><pubmed_authors>Maamari S</pubmed_authors><pubmed_authors>Hulshoff MS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair response.</name><description>&lt;h4>Background&lt;/h4>Cardiac fibrosis is the hallmark of all forms of chronic heart disease. Activation and proliferation of cardiac fibroblasts are the prime mediators of cardiac fibrosis. Existing studies show that ROS and inflammatory cytokines produced during fibrosis not only signal proliferative stimuli but also contribute to DNA damage. Therefore, as a prerequisite to maintain sustained proliferation in fibroblasts, activation of distinct DNA repair mechanism is essential.&lt;h4>Result&lt;/h4>In this study, we report that TET3, a DNA demethylating enzyme, which has been shown to be reduced in cardiac fibrosis and to exert antifibrotic effects does so not only through its demethylating activity but also through maintaining genomic integrity by facilitating error-free homologous recombination</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-04-16T03:23:00.447Z</modification><creation>2025-04-05T18:34:18.262Z</creation></dates><accession>S-EPMC11350970</accession><cross_references><pubmed>39192299</pubmed><doi>10.1186/s13148-024-01719-6</doi></cross_references></HashMap>